ES2175020T3 - Formulacion oftalmica para el uso en la cirugia ocular. - Google Patents
Formulacion oftalmica para el uso en la cirugia ocular.Info
- Publication number
- ES2175020T3 ES2175020T3 ES96120457T ES96120457T ES2175020T3 ES 2175020 T3 ES2175020 T3 ES 2175020T3 ES 96120457 T ES96120457 T ES 96120457T ES 96120457 T ES96120457 T ES 96120457T ES 2175020 T3 ES2175020 T3 ES 2175020T3
- Authority
- ES
- Spain
- Prior art keywords
- eye surgery
- formulation
- ophthalm
- intraocular
- damper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000001356 surgical procedure Methods 0.000 title abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000004744 fabric Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 229940010747 sodium hyaluronate Drugs 0.000 abstract 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCION HACE REFERENCIA A UNA FORMULACION OFTALMICA, PARA UTILIZAR EN LA CIRUGIA DEL OJO, QUE INCLUYE HIALURONATO DE SODIO, CITRATO, AL MENOS UN ANTIOXIDANTE TOLERADO POR LOS TEJIDOS INTRAOCULARES Y UN AMORTIGUADOR DE FOSFATO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95MI002744A IT1277707B1 (it) | 1995-12-22 | 1995-12-22 | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2175020T3 true ES2175020T3 (es) | 2002-11-16 |
Family
ID=11372809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96120457T Expired - Lifetime ES2175020T3 (es) | 1995-12-22 | 1996-12-19 | Formulacion oftalmica para el uso en la cirugia ocular. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5880107A (es) |
EP (1) | EP0781547B1 (es) |
JP (1) | JP4146910B2 (es) |
AT (1) | ATE216221T1 (es) |
CA (1) | CA2193543C (es) |
DE (1) | DE69620724T2 (es) |
DK (1) | DK0781547T3 (es) |
ES (1) | ES2175020T3 (es) |
IT (1) | IT1277707B1 (es) |
PT (1) | PT781547E (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541460B2 (en) | 1996-08-07 | 2003-04-01 | George D. Petito | Method for use of hyaluronic acid in wound management |
US6368585B1 (en) * | 1997-03-25 | 2002-04-09 | Pharmacia Ab | Opthalmic compositions and methods |
US20030138499A1 (en) * | 1998-12-17 | 2003-07-24 | Shah Mandar V. | Stable surgical irrigating solutions |
US6533769B2 (en) * | 2001-05-03 | 2003-03-18 | Holmen Joergen | Method for use in cataract surgery |
US7820194B2 (en) | 2001-12-21 | 2010-10-26 | Alcon, Inc. | Combinations of viscoelastics for use during surgery |
ITMI20020557A1 (it) * | 2002-03-15 | 2003-09-15 | Acraf | Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d |
US20040167480A1 (en) * | 2003-02-21 | 2004-08-26 | Advanced Medical Optics, Inc. | Administration of multiple viscoelastic solutions with a multi-compartment syringe |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US20050215516A1 (en) * | 2004-03-29 | 2005-09-29 | Claudio Bucolo | New free-radical scavenger containing viscoelastic composition, methods of use and package |
US20060073184A1 (en) * | 2004-09-29 | 2006-04-06 | Bausch & Lomb Inc. | Viscoelastic composition, methods of use and packaging device with anti-oxidant |
WO2008042441A1 (en) * | 2006-10-03 | 2008-04-10 | Anthrogenesis Corporation | Use of umbilical cord biomaterial for ocular surgery |
CA2687990A1 (en) * | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Cross-linked collagen and uses thereof |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
SI2818184T1 (sl) | 2007-11-16 | 2019-03-29 | Aclaris Therapeutics, Inc. | Sestava in postopki za zdravljenje purpure |
US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
EP2229180A1 (en) * | 2007-12-27 | 2010-09-22 | D.M.G. Italia Srl | Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
US8450475B2 (en) * | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
JP5722217B2 (ja) | 2008-09-02 | 2015-05-20 | アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエAllergan Holdings France S.A.S. | ヒアルロン酸および/またはその誘導体の糸、その作製方法、ならびにその使用 |
US20100104654A1 (en) * | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
JP4885245B2 (ja) * | 2009-01-15 | 2012-02-29 | 日本航空電子工業株式会社 | Rdコンバータ及び角度検出装置 |
JP2013513622A (ja) * | 2009-12-14 | 2013-04-22 | ユニバーシティ オブ マサチューセッツ | 白内障及び老眼を阻害する方法 |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
CA2792729C (en) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
CA2794254C (en) | 2010-03-22 | 2018-09-04 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
CN103702659B (zh) | 2011-06-03 | 2016-12-21 | 阿勒根公司 | 包括抗氧化剂的皮肤填充剂组合物 |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
EA028008B1 (ru) * | 2012-12-19 | 2017-09-29 | Саркоуд Байосайенс Инк. | Составы ингибитора lfa-1 |
AT514540A1 (de) * | 2013-06-18 | 2015-01-15 | Apomedica Pharmazeutische Produkte Gmbh | Ophthalmische Zusammensetzung |
US9492474B2 (en) | 2013-07-10 | 2016-11-15 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
WO2015125921A1 (ja) * | 2014-02-20 | 2015-08-27 | わかもと製薬株式会社 | 保存効力を有する医薬用水性組成物 |
US10722444B2 (en) | 2014-09-30 | 2020-07-28 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
JP7043392B2 (ja) * | 2015-08-18 | 2022-03-29 | アステラス インスティテュート フォー リジェネレイティブ メディシン | 臨床製剤 |
PL3352766T3 (pl) | 2015-09-24 | 2021-08-02 | Matrix Biology Institute | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
HUE058672T2 (hu) * | 2016-10-14 | 2022-09-28 | I Com Medical Gmbh | Eljárás a szemfelület homeosztázisának megállapítására, helyreállítására és megõrzésére |
CN111386135B (zh) * | 2017-11-22 | 2022-11-08 | 鲍希与洛姆伯股份有限公司 | 眼科粘弹性组合物 |
CN113354757B (zh) * | 2021-06-26 | 2022-04-08 | 上海加新生物科技有限公司 | 一种小分子透明质酸钠的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141973A (en) | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US5409904A (en) * | 1984-11-13 | 1995-04-25 | Alcon Laboratories, Inc. | Hyaluronic acid compositions and methods |
US4886786A (en) * | 1985-08-01 | 1989-12-12 | Lindstrom Richard L | Additive for irrigation solution or surgical solution |
IL80298A (en) | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
US4920104A (en) * | 1988-05-16 | 1990-04-24 | Medchem Products, Inc. | Sodium hyaluronate composition |
DE69116010T2 (de) * | 1990-06-29 | 1996-05-30 | Santen Pharma Co Ltd | Verwendung einer Zusammensetzung zur Herstellung eines Medicamentes zur Entfernung der Reste von Linsenmaterialien |
WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
JPH06107538A (ja) * | 1992-03-31 | 1994-04-19 | Shiseido Co Ltd | 角膜移植用眼球保存液 |
JPH05310580A (ja) * | 1992-04-30 | 1993-11-22 | Shiseido Co Ltd | 眼内灌流用液剤 |
-
1995
- 1995-12-22 IT IT95MI002744A patent/IT1277707B1/it active IP Right Grant
-
1996
- 1996-12-19 DK DK96120457T patent/DK0781547T3/da active
- 1996-12-19 PT PT96120457T patent/PT781547E/pt unknown
- 1996-12-19 ES ES96120457T patent/ES2175020T3/es not_active Expired - Lifetime
- 1996-12-19 AT AT96120457T patent/ATE216221T1/de active
- 1996-12-19 EP EP96120457A patent/EP0781547B1/en not_active Expired - Lifetime
- 1996-12-19 DE DE69620724T patent/DE69620724T2/de not_active Expired - Lifetime
- 1996-12-20 JP JP34218496A patent/JP4146910B2/ja not_active Expired - Fee Related
- 1996-12-20 CA CA002193543A patent/CA2193543C/en not_active Expired - Lifetime
- 1996-12-20 US US08/770,331 patent/US5880107A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69620724T2 (de) | 2002-11-21 |
ITMI952744A1 (it) | 1997-06-22 |
PT781547E (pt) | 2002-09-30 |
IT1277707B1 (it) | 1997-11-11 |
CA2193543C (en) | 2006-02-21 |
JPH09216826A (ja) | 1997-08-19 |
DE69620724D1 (de) | 2002-05-23 |
DK0781547T3 (da) | 2002-08-12 |
JP4146910B2 (ja) | 2008-09-10 |
EP0781547A1 (en) | 1997-07-02 |
EP0781547B1 (en) | 2002-04-17 |
US5880107A (en) | 1999-03-09 |
CA2193543A1 (en) | 1997-06-23 |
ITMI952744A0 (es) | 1995-12-22 |
ATE216221T1 (de) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2175020T3 (es) | Formulacion oftalmica para el uso en la cirugia ocular. | |
ES2078325T3 (es) | Aparato microquirurgico de laser libre de contacto. | |
BR9407330A (pt) | Solução oftálmica baseada em diclofenaco e tobramicina e formulação oftálmica | |
DE69331603D1 (de) | Diffraktive/refraktive brillen- und intraokulare linsenkombination für altersbedingte makulardegenerierung | |
ATE438117T1 (de) | Binokulare linsensysteme | |
BR0302584A (pt) | Combinação de brimonidina e timolol para uso oftálmico tópico | |
CY1106419T1 (el) | Συστημα μετατροπης φακων για τηλεδιοπτρικες ή διαθλαστικες διαταξεις | |
YU46899A (sh) | Kontrolisano oslobadjanje farmaceutika u prednjoj komori oka | |
DE60031861D1 (de) | Mit einer translationszone ausgestattete intraokularlinse | |
EA199700286A1 (ru) | Соединение для офтальмологической хирургии и способ ее осуществления | |
BR0108003A (pt) | Lente intra-ocular de c mara anterior e métodos para reduzir a ovalização da pupila | |
WO2002019949A3 (en) | Intraocular lens with a posterior lens portion | |
BR0107418A (pt) | Lentes de contato que compreendem um corante laranja | |
PT868909E (pt) | Solucao veicular oftalmica | |
BR0116251A (pt) | composição de lágrimas artificiais contendo uma combinação de três demulcentes | |
AU4128901A (en) | Colored visco-elastic composition | |
EP1110554A4 (en) | MEDICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
BR0210013A (pt) | Gel oftálmico de pirenzepina | |
AR022099A1 (es) | Una composicion oftalmica de liberacion sostenida y un metodo para terapia ocular | |
BR112023024835A2 (pt) | Lentes intraoculares com ópticas de mudança de formato e propriedades estabilizadoras | |
AR013273A1 (es) | SISTEMA MATERIAL VISCOELÁSTICO GELIFICABLE FORMADO POR DOS PARTES CON POLíMEROS DE GALACTOMANANO Y BORATO. | |
ES2172485T1 (es) | Composiciones oftalmicas en forma de gel acuoso. | |
BR9712308A (pt) | Inibidor de catarata secundária | |
ES2078175B1 (es) | Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones. | |
DE69106777D1 (de) | Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 781547 Country of ref document: ES |